23 reports

One unit consists of one disposable insulin pump.

  • Hepatitis
  • Insulin
  • Insulin Delivery
  • Stroke
  • Roche Group

It offers products such as antirheumatic agent, antibacterial agent, antiviral agent and antifungal agents, among others.

  • Hepatitis
  • Pharmaceutical
  • Stroke
  • Therapy
  • Eisai Co., Ltd.

One unit refers to one disposable insulin pen.

  • Healthcare
  • Hepatitis
  • Insulin
  • Stroke
  • Pfizer Inc.

Similarly, the universities portfolio in Preclinical and Discovery stages comprises ## and ## molecules, respectively.

  • Hepatitis
  • Insulin
  • Stroke
  • United States
  • Product Initiative

PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RA WHO HAD AN INADEQUATE RESPONSE TO AT LEAST ONE DISEASE- MODIFYING ANTIRHEUMATIC DRUG (DMARD) RECEIVED TASOCITINIB ## MG OR ## MG MONOTHERAPY OR PLACEBO TWICE A DAY.

  • Hepatitis
  • Insulin
  • Medical Biotechnology
  • Stroke
  • Pfizer Inc.

SR One Ltd.

  • Hepatitis
  • Insulin
  • Stroke
  • United States
  • Bristol-Myers Squibb Company

One external remote patient monitoring device consists of one external module or transmitter.

  • Cardiovascular Disease
  • Insulin
  • Stroke
  • United States
  • Pfizer Inc.

One unit refers to one disposable insulin pen.

  • Healthcare
  • Hepatitis
  • Insulin
  • Stroke
  • Sanofi S.A.

In August 2011, AB Science registered a Phase II/ III multicenter, randomized, double-blind, controlled, ##-parallel groups study to compare efficacy and safety of masitinib at ## and ## mg/ kg/ day to methotrexate, with a randomization ##:##:##, in treatment of pati

  • Hepatitis
  • Pharmaceutical
  • Stroke
  • Therapy
  • Merck & Co., Inc.

FURTHERMORE, CGEN-## SHOWED EFFICACY SIMILAR TO THAT OBSERVED THROUGH TNF-ALPHA BLOCKADE WITH TNFR-FC, ENBREL, A WIDELY USED BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUG (DMARD).

  • Hepatitis
  • Insulin
  • Stroke
  • United States
  • Company

SR One Ltd.

  • Hepatitis
  • Insulin
  • Stroke
  • United States
  • Bristol-Myers Squibb Company
  • STROKE - PIPELINE BY SAVARA INC, H1 2018
  • STROKE - PIPELINE BY SHIN POONG PHARMCO LTD, H1 2018

The company provides cardiovascular, psychoneurotic, anti-cancer, antihistamine, antirheumatic and benign prostatic hyperplasia drugs.

  • Hepatitis
  • Insulin
  • Stroke
  • Company
  • Product Initiative

Vidofludimus belongs to the class of disease-modifying drugs known as DMARDs (disease-modifying antirheumatic drugs).

  • Hepatitis
  • Pathology
  • Therapy
  • World
  • 4SC AG
  • ACUTE ISCHEMIC STROKE - PIPELINE BY SIMCERE PHARMACEUTICAL GROUP, H1 2016

In August 2011, AB Science registered a Phase II/ III multicenter, randomized, double-blind, controlled, ##-parallel groups study to compare efficacy and safety of masitinib at ## and ## mg/ kg/ day to methotrexate, with a randomization ##:##:##, in treatment of pati

  • Hepatitis
  • Insulin
  • Research And Development
  • Stroke
  • AB Science SA

The guidance does not recommend abatacept in combination with methotrexate, for treating rheumatoid arthritis in adults whose disease has responded inadequately to one or more conventional non-biological disease modifying anti-rheumatic drugs (DMARDs) including methotrexate.

  • Hepatitis
  • Lung Cancer
  • Stroke
  • United States
  • Ono Pharmaceutical Co., Ltd.
  • ACUTE ISCHEMIC STROKE - PIPELINE BY SIMCERE PHARMACEUTICAL GROUP, H2 2016

In August 2011, AB Science registered a Phase II/ III multicenter, randomized, double-blind, controlled, ##-parallel groups study to compare efficacy and safety of masitinib at ## and ## mg/ kg/ day to methotrexate, with a randomization ##:##:##, in treatment of pati

  • Hepatitis
  • Insulin
  • Stroke
  • Product Initiative
  • AB Science SA
  • CIRRHOSIS. THE TRIAL WAS REGISTERED WITH THE U.S. NATIONAL INSTITUTES OF HEALTH.

Eisai and Abbott (now Abbvie, Inc. ) signed a supplemental agreement for the joint development of the new indication, psoriasis, of the anti-rheumatic agent adalimumab in Japan.

  • Hepatitis
  • Monoclonal Antibody
  • Stroke
  • United States
  • AbbVie Inc.

Actemra is used for the treatment of rheumatoid arthritis in adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more disease modifying anti-rheumatic drugs.

  • Cancer
  • Hepatitis
  • Insulin
  • Stroke
  • United States

The purpose of the study is to assess the efficacy and safety of secukinumab in patients with active ankylosing spondylitis who are tolerant to or have had an inadequate response to non steroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs DMARDs and/ or TNF

  • Cancer
  • Hepatitis
  • Insulin
  • Stroke
  • Novartis AG

BUT IT IS ONE OF THE MOST IMPORTANT POINTS!

  • Hepatitis
  • Insulin
  • Stroke
  • Roche Group
  • Sandoz Inc.

Golimumab (Simponi ARIA, Simponi) is a human monoclonal antibody, acts as immunosuppressant and antirheumatic agent.

  • Hepatitis
  • Insulin
  • Monoclonal Antibody
  • Stroke
  • United States

The guidance does not recommend abatacept in combination with methotrexate, for treating rheumatoid arthritis in adults whose disease has responded inadequately to one or more conventional non-biological disease modifying anti-rheumatic drugs (DMARDs) including methotrexate.

  • Hepatitis
  • Insulin
  • Research And Development
  • Stroke
  • United States